Saturday, November 14, 2026

U.S. Gulf Coast Adds 400,000 Barrel-Per-Day LPG Terminal Targeting Asian Markets

A 400,000 barrel-per-day LPG export terminal will open on the U.S. Gulf Coast in 2028, adding 20% capacity to American liquefied petroleum gas infrastructure. The facility targets Asian petrochemical demand and European heating markets, where U.S. suppliers compete with Middle Eastern exporters for a growing 115 million ton global trade.

ViaNews Editorial Team

February 21, 2026

From our archive, published before source-traceability. How we work

Source Trace Score1 source document1 with a live linkVerifiability: Basic
U.S. Gulf Coast Adds 400,000 Barrel-Per-Day LPG Terminal Targeting Asian Markets
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

A 400,000 barrel-per-day LPG export terminal will launch on the U.S. Gulf Coast in 2028, expanding American capacity by 20% as global trade in liquefied petroleum gas reached 115 million tons in 2023.

The facility targets Asian markets where Japan, South Korea, and China collectively import over 30 million tons annually for petrochemical production. European buyers increased U.S. LPG imports 40% after 2022 energy disruptions reduced Russian supply access.

U.S. exporters captured 23% of global LPG trade in 2023, trailing Middle Eastern suppliers at 41%. American terminals compete on delivery reliability and contract flexibility rather than price, as Gulf Coast proximity to Panama Canal cuts Asian transit time by 10-14 days versus Atlantic routes.

Asian spot prices averaged $550-650 per ton in 2023-2024, maintaining $200 margins over U.S. benchmark prices at Mont Belvieu. The arbitrage supports infrastructure investment despite competition from Qatar and Saudi Arabia, where integrated refining operations produce LPG at lower costs.

U.S. LPG exports reached 1.8 million barrels daily in 2023, with propane and butane flowing primarily to Asian petrochemical facilities and European residential heating markets. Existing Gulf Coast terminals operate at 85-90% utilization during peak winter demand.

The terminal operates under long-term contracts with petrochemical companies and commodity traders, using fee-based revenue models that reduce exposure to price volatility. Midstream operators view export infrastructure as stable cash flow assets tied to sustained Permian Basin production growth.

The 2028 timeline aligns with projected demand increases in key Asian import markets. U.S. suppliers aim to reach 30% global market share by 2030, requiring continued infrastructure expansion as international LPG consumption grows with petrochemical capacity additions in China and Southeast Asia.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score1 source document1 with a live linkVerifiability: Basic
  1. [1]News articleYahoo Finance· February 20, 2026
    MPLX LP: Why This Midstream MLP Deserves a Premium Valuation
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com